Efficacy and safety of oral basal insulin: eight-week feasibility study in people with type 2 diabetes

被引：0
|
作者：
Plum-Moerschel, L. [1 ]
Heise, T. [2 ]
Zijlstra, E. [2 ]
Lyby, K. [3 ]
Wassermann, K. [3 ]
Bronsted, L. [3 ]
Halberg, I. B. [3 ]
机构：
[1] Profil, Mainz, Germany
[2] Profil, Neuss, Germany
[3] Novo Nordisk AS, Soborg, Denmark
来源：
DIABETOLOGIA | 2017年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
74
引用
收藏
页码：S35 / S35
页数：1
相关论文
共 50 条
  • [1] Efficacy and Safety of Oral Basal Insulin: Eight-Week Feasibility Study in People with Type 2 Diabetes (T2DM)
    Plum-Moerschel, Leona
    Heise, Tim
    Zijlstra, Eric
    Lyby, Karsten
    Wassermann, Karsten
    Brondsted, Lise
    Halberg, Inge Birk
    [J]. DIABETES, 2017, 66 : A100 - A100
  • [2] Effects of an eight-week Endurance Training on Fructosamine Content in People with Type 1 Diabetes
    Mueller, Alexander
    Moser, Othmar
    Eckstein, Max Lennard
    Birnbaumer, Philipp
    Aberer, Felix
    Koehler, Gerd
    Sourij, Caren
    Kojzar, Harald
    Pferschy, Peter
    Hofmann, Peter
    Sourij, Harald
    [J]. WIENER KLINISCHE WOCHENSCHRIFT, 2019, 131 : S483 - S483
  • [3] Efficacy and safety of linagliptin as add-on therapy to basal insulin and metformin in people with Type 2 diabetes
    Duran-Garcia, S.
    Lee, J.
    Yki-Jarvinen, H.
    Rosenstock, J.
    Hehnke, U.
    Thiemann, S.
    Patel, S.
    Woerle, H. -J.
    [J]. DIABETIC MEDICINE, 2016, 33 (07) : 926 - 933
  • [4] Efficacy of a basal insulin titration app on glycaemic outcomes in people with type 2 diabetes on an oral-basal insulin regimen: results of an RCT
    Hermanns, N.
    Ehrmann, D.
    Groene, K. Finke
    Roos, T.
    Kulzer, B.
    [J]. DIABETOLOGIA, 2023, 66 (SUPPL 1) : S417 - S417
  • [5] Efficacy and Safety of Insulin Glargine 300 U/mL in People with Type 2 Diabetes Uncontrolled on Basal Insulin: The 26-Week Interventional, Single-Arm ARTEMIS-DM Study
    Bipin Sethi
    Khalid Al-Rubeaan
    Mustafa Unubol
    Maria A. Mabunay
    Baptiste Berthou
    Valerie Pilorget
    Shireene R. Vethakkan
    Gustavo Frechtel
    [J]. Diabetes Therapy, 2022, 13 : 1395 - 1408
  • [6] Efficacy and Safety of Insulin Glargine 300 U/mL in People with Type 2 Diabetes Uncontrolled on Basal Insulin: The 26-Week Interventional, Single-Arm ARTEMIS-DM Study
    Sethi, Bipin
    Al-Rubeaan, Khalid
    Unubol, Mustafa
    Mabunay, Maria A.
    Berthou, Baptiste
    Pilorget, Valerie
    Vethakkan, Shireene R.
    Frechtel, Gustavo
    [J]. DIABETES THERAPY, 2022, 13 (07) : 1395 - 1408
  • [7] Safety and efficacy of once-weekly basal insulin Fc in people with type 2 diabetes previously treated with basal insulin: a multicentre, open-label, randomised, phase 2 study
    Frias, Juan
    Chien, Jenny
    Zhang, Qianyi
    Chigutsa, Emmanuel
    Landschulz, William
    Syring, Kristen
    Wullenweber, Paula
    Haupt, Axel
    Kazda, Christof
    [J]. LANCET DIABETES & ENDOCRINOLOGY, 2023, 11 (03): : 158 - 168
  • [8] Feasibility and Safety of an Eight-Week Exercise Program with the Additional Peripheral Magnetic Stimulation of the Abdominal Muscles
    Ivezic, Denisa Manojlovic
    Zitnik, Jure
    Sarabon, Nejc
    [J]. HEALTHCARE, 2024, 12 (14)
  • [9] Switching the basal insulin to insulin glargine 300 U/ml in people with type 2 diabetes under basal insulin supported oral therapy: Observational trial on effectiveness and safety
    Seufert, Jochen
    Wiesli, Peter
    Fritsche, Andreas
    Anderten, Helmut
    Pegelow, Katrin
    Pscherer, Stefan
    Pfohl, Martin
    [J]. DIABETES OBESITY & METABOLISM, 2022, 24 (01): : 72 - 81
  • [10] Efficacy and safety of oral basal insulin versus subcutaneous insulin glargine in type 2 diabetes: a randomised, double-blind, phase 2 trial
    Halberg, Inge B.
    Lyby, Karsten
    Wassermann, Karsten
    Heise, Tim
    Zijlstra, Eric
    Plum-Moerschel, Leona
    [J]. LANCET DIABETES & ENDOCRINOLOGY, 2019, 7 (03): : 179 - 188
12345